MS Speaks
Multiple Sclerosis => TREATMENTS => OCREVUS (ocrelizumab) => Topic started by: agate on August 04, 2018, 08:32:29 am
-
Multiple Sclerosis Journal often publishes a "yes" and "no" side to a debate, accompanied by a commentary. The August issue's debate topic is whether rituximab is an acceptable alternative to ocrelizumab in treating MS.
The "Yes" side:
http://journals.sagepub.com/doi/full/10.1177/1352458518757930
The "No" side:
http://journals.sagepub.com/doi/full/10.1177/1352458518757931
And the Commentary:
http://journals.sagepub.com/doi/full/10.1177/1352458518760717